⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KYMR News
Kymera Therapeutics, Inc. Common Stock
Kymera International Appoints Willson Ropp as Chief Executive Officer
prnewswire.com
KYMR
Kymera Therapeutics to Report Second Quarter 2026 Financial Results on August 5, 2026
globenewswire.com
KYMR
Form 8-K
sec.gov
KYMR
Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer
globenewswire.com
KYMR
Kuehn Law Encourages Investors of Kymera Therapeutics, Inc. to Contact Law Firm
prnewswire.com
KYMR
Kuehn Law Encourages Investors of Kymera Therapeutics, Inc. to Contact Law Firm
globenewswire.com
KYMR
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Kymera Therapeutics, Inc. (NASDAQ: KYMR)
prnewswire.com
KYMR
Kymera Therapeutics Appoints Elizabeth Laws, Ph.D., as Senior Vice President, Global Program Team Leader for KT-621, First-in-Class, Oral STAT6 Degrader
globenewswire.com
KYMR
Form 8-K
sec.gov
KYMR
Kymera Therapeutics Completes Enrollment in the Phase 2b BROADEN2 Trial of KT-621 in Atopic Dermatitis with Topline Data by Year-end 2026
globenewswire.com
KYMR